Onyx Pharmaceuticals Inc
(NASDAQ: ONXX)
+0.30
+0.31%
| Shares Outstanding | 73.00 Mil |
| Institutional Ownership (%) | NA |
| Top 10 Institutions (%) | 49.90 |
| Mutual Fund Ownership (%) | 1.58 |
| 5%/Insider Ownership (%) | 1.04 |
| Float (%) | 98.96 |
| DESCRIPTION | # OF HOLDERS | SHARES |
|---|---|---|
| Total Positions | 280 | 74,280,890 |
| New Positions | 47 | 0 |
| Soldout Positions | 135 | 0 |
| Net Position Change | -58 | -4,472,231 |
| Buyers | 166 | 11,323,895 |
| Sellers | 224 | -15,796,126 |
| MUTUAL FUND | SHS HELD | SHS CHG | %CHG | $CHG* | %OUT | %PORT | RPT DATE |
|---|---|---|---|---|---|---|---|
| JPMorgan Large Cap Growth Fund | 1,357,400 | 65,400 | 5.1 | 23,033,804 | 1.9 | 1.1 | 03-31-13 |
| Fidelity Select Biotechnology Portfolio | 1,281,245 | 0 | 0 | 17,078,996 | 1.8 | 2.8 | 03-31-13 |
| T. Rowe Price Health Sciences Fund | 1,105,000 | 130,000 | 13.3 | 24,548,550 | 1.5 | 1.6 | 03-31-13 |
| Statens Pensjonsfond Utland | 1,097,337 | -354,281 | -24.4 | 19,083,253 | 1.5 | 0 | 12-31-12 |
| Vanguard Small-Cap Index Fund | 1,073,211 | 1,073,211 | 1 | 95,365,530 | 1.5 | 0.3 | 03-31-13 |
| Fidelity Capital Appreciation Fund | 1,051,264 | 245,482 | 30.5 | 32,554,605 | 1.4 | 1.4 | 03-31-13 |
| Vanguard Health Care Fund | 1,022,700 | 0 | 0 | 13,632,591 | 1.4 | 0.4 | 03-31-13 |
| T. Rowe Price Mid-Cap Growth Fund | 1,000,000 | 0 | 0 | 13,330,000 | 1.4 | 0.5 | 03-31-13 |
| Vanguard Total Stock Market Index Fund | 999,143 | 128,547 | 14.8 | 23,027,731 | 1.4 | 0 | 03-31-13 |
| T. Rowe Price Growth Stock Fund | 936,315 | 28,415 | 3.1 | 14,627,264 | 1.3 | 0.3 | 03-31-13 |
| Wells Fargo Advantage Growth Fund | 890,000 | 115,000 | 14.8 | 20,549,650 | 1.2 | 0.7 | 03-31-13 |
| iShares NASDAQ Biotechnology Index Fund | 859,334 | 87,459 | 11.3 | 18,060,700 | 1.2 | 2.9 | 03-31-13 |
| Lord Abbett Securities Trust - Fundamental Equity Fund | 739,200 | 60,800 | 9 | 14,445,760 | 1 | 1.3 | 03-31-13 |
| Fidelity Select Health Care Portfolio | 700,000 | 400,000 | 133.3 | 39,543,000 | 1 | 2.1 | 03-31-13 |
| Vanguard Explorer Fund | 697,909 | 23,707 | 3.5 | 11,093,717 | 1 | 0.6 | 03-31-13 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.